GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4basebio PLC (XTER:88Q) » Definitions » Other Stockholders Equity

4basebio (XTER:88Q) Other Stockholders Equity : €16.14 Mil (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is 4basebio Other Stockholders Equity?

4basebio's Other Stockholders Equity for the quarter that ended in Jun. 2023 was €16.14 Mil.

4basebio's quarterly Other Stockholders Equity increased from Jun. 2022 (€15.91 Mil) to Dec. 2022 (€16.11 Mil) and increased from Dec. 2022 (€16.11 Mil) to Jun. 2023 (€16.14 Mil).

4basebio's annual Other Stockholders Equity increased from Dec. 2020 (€15.43 Mil) to Dec. 2021 (€15.81 Mil) and increased from Dec. 2021 (€15.81 Mil) to Dec. 2022 (€16.11 Mil).


4basebio Other Stockholders Equity Historical Data

The historical data trend for 4basebio's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4basebio Other Stockholders Equity Chart

4basebio Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Other Stockholders Equity
1.62 15.43 15.81 16.11

4basebio Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Other Stockholders Equity Get a 7-Day Free Trial 15.76 15.81 15.91 16.11 16.14

4basebio Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


4basebio Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of 4basebio's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


4basebio (XTER:88Q) Business Description

Industry
Traded in Other Exchanges
Address
25 Norman Way, Over, Cambridge, GBR, CB24 5QE
4basebio PLC is a life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for the effective and safe delivery of these DNA-based products to patients. Its country of operation is the UK. It is engaged in the manufacturing and supply of high-purity, synthetic DNA for research, therapeutic and pharmacological use.

4basebio (XTER:88Q) Headlines

No Headlines